HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-02-28Clinical Trial Update: Impact of Anti-HIV Treatment on Labor Productivity and Costs in South Africa
A clinical trial studying the impact of anti-HIV treatment on labor productivity and costs in South Africa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-08Clinical Trial Update: Dapivirine Gel Rectal Safety and PK Study [Phase 1]
A Phase 1 safety and pharmacokinetics study of rectal dapivirine gel has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-02Clinical Trial Update: A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence [Phase 2]
Phase 2 trial of PRO 140 (leronlimab), a monoclonal CCR5 antibody, as an adjunct to an optimized oral antiretroviral regimen in HIV-infected…
-
CLINICAL_TRIALS withdrawal · 2017-01-24Clinical Trial Update: Computer-Based Intervention in HIV-Positive Young Adults [NA]
The clinical trial NCT02544126 evaluating a computer-based intervention for HIV-positive young adults with depression has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-19Clinical Trial Update: Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients
This clinical trial investigating muscle spectroscopy to evaluate mitochondrial dysfunction in HIV-infected patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-12-14Clinical Trial Update: A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) [NA]
This clinical trial evaluating L-735,524, an HIV protease inhibitor, in combination with interleukin-2 in HIV-infected individuals has been …
-
CLINICAL_TRIALS withdrawal · 2016-12-14Clinical Trial Update: Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating daily tenofovir disoproxil fumarate to prevent HIV infection among sex workers in Cambodia has been withd…
-
CLINICAL_TRIALS withdrawal · 2016-10-28Clinical Trial Update: PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354. [Phase 1]
A first-in-human Phase 1 trial of Tibotec compounds TMC589337 and TMC589354 (single-dose escalation and multiple-dosing parts) has been with…
-
CLINICAL_TRIALS withdrawal · 2016-08-24Clinical Trial Update: ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression. [Phase 4]
The Phase 4 ESP Study evaluating adding Fuzeon (enfuvirtide) to an antiretroviral regimen in fuzeon-naive patients with sustained HIV suppre…
-
CLINICAL_TRIALS withdrawal · 2016-08-22Clinical Trial Update: Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV [Phase 4]
A Phase 4 clinical trial evaluating anal dysplasia in men who have sex with men living with HIV has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-04Clinical Trial Update: Maraviroc Compassionate Use [Phase 3]
A Phase 3 compassionate-use trial of Maraviroc for HIV-1 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-01Clinical Trial Update: Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation [Phase 2]
A Phase 2 clinical trial comparing HAART to statin therapy in HIV infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-10Clinical Trial Update: A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa [Phase 1, Phase 2]
A Phase 1/2 safety study of the dapivirine vaginal gel for HIV prevention in South Africa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: HIV-discordant Couple Intrauterine Insemination
Clinical trial update noting that the HIV-discordant couple intrauterine insemination study sponsored by the University of Missouri-Columbia…
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
A clinical trial evaluating the safety and effectiveness of darunavir for HIV-1 infection in Filipino patients has been withdrawn from the r…
-
CLINICAL_TRIALS withdrawal · 2015-11-05Clinical Trial Update: Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa [Phase 2]
Phase 2 trial evaluating the safety and acceptability of cabotegravir in HIV-uninfected women in KwaZulu-Natal, South Africa has been withdr…
-
CLINICAL_TRIALS withdrawal · 2015-11-03Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations
This clinical trial update reports pharmacokinetics and pharmacodynamics of an anti-HIV drug in Israeli Ethiopian and non-Ethiopian populati…
-
CLINICAL_TRIALS withdrawal · 2015-10-02Clinical Trial Update: HIV-1 Vaccine Test in Uninfected Adult Volunteers [Phase 1]
A Phase 1 HIV-1 vaccine trial in uninfected adult volunteers was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-01Clinical Trial Update: Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
The observational trial evaluating antiretroviral response in African children using viral load monitoring has been withdrawn. No results ar…
-
CLINICAL_TRIALS withdrawal · 2015-09-28Clinical Trial Update: Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease [Phase 4]
A Phase 4 clinical trial evaluating rifaximin for liver scarring in HIV-infected individuals with liver disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-28Clinical Trial Update: Dolutegravir + Rilpivirine Switch Study (DORISS) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating switching to a dolutegravir + rilpivirine regimen in virologically controlled HIV infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-05Clinical Trial Update: Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
The clinical trial evaluating optimizing antiretroviral therapy in HIV-infected children and adolescents has been terminated.
-
CLINICAL_TRIALS withdrawal · 2015-07-23Clinical Trial Update: Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma [Phase 2]
Phase 2 trial of the gamma secretase inhibitor PF-03084014 for AIDS-related Kaposi sarcoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Safety Study of Raltegravir in HIV/HCV Co-infected Patients [Phase 4]
A Phase 4 safety study of raltegravir in patients co-infected with HIV and hepatitis C has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China [Phase 1]
A Phase 1 HIV education trial conducted in Funan County or Yingzhou District, Anhui Province, China was withdrawn.